Kerosar Tablets (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
MFDS item code 202002997 · Approved 2020.04.24
This product's status changed to Approval withdrawn on 2025.03.27. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of hypertension and diabetic nephropathy in patients with type 2 diabetes and hypertension
This medication is used to treat hypertension. It is especially helpful in treating kidney diseases in patients with type 2 diabetes who have hypertension. It is effective in preventing and improving kidney complications associated with hypertension.
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. Hypertension - Adults: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after initiation of treatment. If the treatment effect is insufficient, the same dose may be divided and administered orally twice daily, or the dose may be increased to 100 mg once daily if necessary. If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used blood glucose-lowering agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). Elderly patients: No initial dose adjustment is necessary in elderly patients 75 years or younger. For elderly patients over 75 years, an initial dose of 25 mg of this medicine once daily is recommended. Patients with renal impairment - Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is necessary. Patients with renal impairment - Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. Patients with reduced effective intravascular volume: An initial dose of 25 mg of this medicine once daily is recommended for patients who may have reduced effective intravascular volume (e.g., patients being treated with diuretics) (see Precautions for Use). Patients with hepatic impairment: A lower dose should be considered for patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents aged 6 years or older who weigh 20 kg or more and less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents aged 6 years or older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.
This medication can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters, so it should be stopped immediately upon confirmation of pregnancy. Patients who have an allergy to this medication, are pregnant, have severely impaired liver function, have a history of certain vascular angioedema, or have primary hyperaldosteronism should not take this medication. Elderly patients, those with hyperkalemia, patients with slightly impaired liver function, patients with heart or vascular diseases, and patients with impaired kidney function should use this medication with caution and have their conditions closely monitored by a physician. Side effects may include muscle cramps, dizziness, cold symptoms, and dyspepsia, and in rare cases may lead to angioedema, liver dysfunction, muscle damage, or severe skin reactions, thus any unusual symptoms should be reported to a doctor immediately. Patients with impaired liver function may need their dose adjusted due to increased drug concentration, and caution is needed in those with impaired kidney function as well. During treatment with this medication, blood pressure, kidney function, and serum electrolyte levels should be regularly monitored, especially since there is a risk of elevated potassium levels; potassium supplements or potassium-containing salt substitutes should not be taken without consulting a physician. When taking this medication with other antihypertensives, diuretics, non-steroidal anti-inflammatory drugs, lithium, and other medications, interactions may occur, so it is crucial to inform the physician of all medications being taken. If severe hypotension, loss of consciousness, severe hepatitis symptoms, or renal failure symptoms occur while taking this medication, it should be discontinued immediately and medical treatment sought. This medication is not recommended for children, especially those under 6 years of age or children with severely impaired kidney function, as its safety and efficacy have not been established. Women of childbearing potential must confirm their pregnancy status before taking this medication, avoid its use during pregnancy, and breastfeeding women should discontinue breastfeeding while taking this medication. Dizziness or drowsiness may occur when taking this medication; caution is advised when driving or operating machinery, particularly at the beginning of treatment or when changing doses. In the case of overdose, hypotension and changes in heart rate may occur, necessitating immediate medical attention, and this medication is not removed through hemodialysis. This medication should be stored out of reach of children, and transferring it to another container should be avoided to maintain quality and safety.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is best to maintain a room temperature between 1 and 30 degrees Celsius.
White oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Losartan Potassium 50mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.